HIT Application Solutions announced a partnership with Merge Healthcare Inc. to integrate its Notifi platform with Merge RIS, a Meaningful Use (MU) outpatient radiology information system. The solution, to be marketed as Merge Notifi, will initially automate appointment reminders and make patient results available through messages for Merge customers. Merge Notifi is a HIPPA compliant service. 

Claron Technology will debut at HIMSS 2014 enhancements for a streamlined image and video upload for both mobile devices and desktop PCs. This will add functionality to its family of Nil universal, zero-footprint viewers. The technology requires a browser only, not installation of an app or engine. The technology supports mobile devices and allows zero-footprint upload of both digital imaging and communications in medicine (DICOM) and non-DICOM data from notebook and desktop computers.  

The U.S. Food and Drug Administration (FDA) cleared Carestream Health’s Vue Motion image viewer for clinical viewing and reading of medical X-ray exams using iPhone 4s, iPad 2, Galaxy Note and Galaxy S III mobile devices.  

Fovia, Inc. and Visual Medica announced a collaboration to deliver innovative, cost-effective advanced visualization to the Latin American market.

HealthMed Holdings completed validation on a blood test that aims to identify individuals who are at risk of a heart attack and may be missed by conventional tests. 

These individuals have no symptoms and frequently have normal standard blood cholesterol profiles, but are at significant risk of having a heart attack in the near term. The group is actively commercializing the test.

Carestream is sponsoring an executive panel discussion at the HIMSS 2014 meeting, Feb. 25, from 3:30 to 4:30 p.m. in Room 202C at the Orlando Convention Center. The title is “Executive Perspective: How to Achieve Efficient Enterprise Data Management” and the session is open to all HIMSS attendees. Jennifer Horowitz, Senior Director of Research for HIMSS Analytics, will be the moderator.


A team of interventional cardiologists and cardiovascular surgeons at The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann Heart & Vascular Institute-Texas Medical Center performed Texas’ first transcatheter aortic valve replacement (TAVR) under conscious sedation using the Edwards Sapien valve.

The U.S. Food and Drug Administration (FDA) granted AliveCor Inc. over-the-counter (OTC) clearance for the AliveCor Heart Monitor, a single-channel ECG (electrocardiogram) recorder, previously available by prescription only. The device is available for pre-order purchase with shipments beginning in March.

Subscribe Now